Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study White survivors of childhood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback